Miami Cancer Institute Names Govindarajan Narayanan, M.D., Chief Of Interventional Oncology

MIAMI, FL — September 4, 2018 — Renowned interventional radiologist Govindarajan Narayanan, M.D., has joined the clinical teams at two of Baptist Health South Florida’s premiere service lines – Miami Cardiac and Vascular Institute, the area’s largest and most comprehensive cardiovascular facility, and Miami Cancer Institute, a next-generation cancer center and Florida’s only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, where he has been named Chief of Interventional Oncology.

Dr. Narayanan brings a wealth of academic, clinical and research expertise. He comes to Baptist Health from the University of Miami Leonard M. Miller School of Medicine, where he was the founding chair of the Department of Interventional Radiology and held the titles of Professor of Interventional Radiology and Professor of Urology. A member of numerous professional and honorary organizations, he is also a pioneer in his field, developing the technique of percutaneous irreversible electroporation (IRE) of the pancreas. In his new role, Dr. Narayanan will lead Miami Cancer Institute’s division of Interventional Oncology, which has become an essential component of its comprehensive, multidisciplinary model of oncologic care.

“The appointment of Dr. Narayanan to this important, clinical leadership role is a testament to the benefits of minimally invasive surgical techniques and to our dedication to collaborative, multidisciplinary cancer care,” said Michael J. Zinner, M.D., founding CEO and executive medical director of Miami Cancer Institute. “Dr. Narayanan is among the best in his field, having pioneered many of the specialized clinical applications in interventional radiology that are used today. He will work in close coordination with care teams at both Institutes to plan and deliver personalized treatments that profoundly impact outcomes.”

Dr. Narayanan’s discipline includes residency training in nuclear medicine at Methodist Hospital of Brooklyn and Memorial Sloan Kettering Cancer Center in New York, as well as a residency in diagnostic radiology at St. Barnabas Medical Center in Livingston, New Jersey. His fellowship years encompassed training in interventional radiology at the Medical University of South Carolina in Charleston and Stony Brook University Hospital in New York. Dr. Narayanan is board-certified in diagnostic radiology and holds a Certificate of Added Qualification in interventional radiology.

Dr. Narayanan’s primary clinical research interests include pancreatic, liver and colon cancer. He is widely published in such prestigious medical journals as Cancer, Journal of Vascular and Interventional Oncology and Cardiovascular & Interventional Radiology and serves as a reviewer and editor for several scientific publications. His published work on Percutaneous IRE of the pancreas was honored as a distinguished study of the year at the 2018 Society of Interventional Radiology Annual meeting. He also is an invited faculty member and speaker at several national and international scientific meetings.

Highly skilled interventional radiologists such as Dr. Narayanan are uniquely qualified to diagnose cancer and to treat the disease utilizing targeted, minimally invasive procedures performed under image guidance. The scope of interventional oncologic interventions includes tumor ablation, chemoembolization and radioembolization. These advanced interventions also can be used to manage pain and alleviate a variety of other cancer associated symptoms. Because incisions are small and the procedures are quick and precise, side effects and recovery time are minimal.

# # #

About Miami Cancer Institute
Miami Cancer Institute is a next-generation cancer treatment destination known for its leading clinical care and research, compassionate patient experience and state-of-the-art technology – including the first proton therapy center in South Florida, Latin America and the Caribbean, and the only radiation oncology program in the world with each of the latest radiation therapies in one place. The Institute offers an impressive roster of established community oncologists and renowned cancer experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. As Florida’s only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, Miami Cancer Institute is part of a deep and functional collaboration that affords patients access to innovative treatments right here at home and ensures that the standards of care developed by our multidisciplinary disease management teams match those at MSK. Heralded nationally as one of the “hybrid” cancer centers of the future, Miami Cancer Institute combines high-quality community-based cancer care with the best of an academic cancer center, including innovative clinical trials tied to research and genomics and disease-specific surgeons, medical oncologists and radiation oncologists who are experts in their fields. For more information, visit MiamiCancerInstitute.com.

Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with 10 hospitals (Baptist Hospital, Baptist Children’s Hospital, Bethesda Hospital East, Bethesda Hospital West, Doctors Hospital, Fishermen’s Community Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital), more than 40 physician practices, 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence spanning across Monroe, Miami-Dade, Broward and Palm Beach counties. A not-for-profit organization supported by philanthropy and committed to our faith-based charitable mission of medical excellence, Baptist Health has more than 19,500 employees and more than 3,000 affiliated physicians. Baptist Health South Florida has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/newsroom and connect with us on Facebook at facebook.com/BaptistHealthSF and on Twitter and Instagram @BaptistHealthSF.